glp-1 fda shortage FDA's decision kicks off 'unprecedented' tussle over GLP-1 Drugs: FDA Sued Over

CBO is assuming a cheaper per-user price from Part D rebates in the first year and then Medicare negotiations starting in 2027

Breaking Down The Titration Schedule A titration schedule is a step-by-step plan for increasing your medication dose over time

For tirzepatide (Mounjaro/Zepbound), standard starts at 2.5 mg

New GLP-1 coverage is not through Part D While the program isnt a Part D offering, Medicare enrollees can participate only if theyre in an eligible Part D stand-alone drug plan in original Medicare or an eligible Medicare Advantage plan that provides prescription drug coverage

When dose adjustment is not necessary Mild to moderate heartburn that responds to dietary changes, lifestyle modifications, or OTC medications does not require a dose change